Schedule 13G ownership disclosure

SYROS PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 87184Q107

Event date: 2024-07-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-193053
Form type
SC 13G/A
Filer
Invus Global Management, LLC
CIK
CIK 2005369
Filed
Aug 02, 2024
Reporting period
Jul 25, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub